 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Durezol |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a609025 |
| License data | |
| Routes of administration | Eye drops |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.041.636 |
| Chemical and physical data | |
| Formula | C27H34F2O7 |
| Molar mass | 508.559 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Difluprednate, sold under the brand nameDurezol, is acorticosteroid used for the treatment of post-operative ocular inflammation and pain.[1]
It was approved for medical use in the United States in June 2008.[1][2][3] It is available as ageneric medication.[4]
Difluprednate isindicated for the treatment of inflammation and pain associated with ocular surgery; and the treatment of endogenous anterior uveitis.[1]
Difluprednate ophthalmic emulsion 0.05% is also being studied in other ocular inflammatory diseases, including a phase 3 study evaluating difluprednate for the treatment of anterioruveitis[5][6]
 | Thisdermatologicdrug article is astub. You can help Wikipedia byexpanding it. |